Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHINK: NK Cells Post-Haplo Transplant
NCT05304754Phase 2Active, not recruiting
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Nov 2020
- Primary completion
- Jun 2026
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of IL-15-stimulated NK cells in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), chronic myeloid leukemia (CML), Hodgkin lymphoma (HL), sponsored by Hospital La Paz Institute for Health Research. Started Nov 2020; status: active, not recruiting.
02
Drugs
IL-15-stimulated NK cells
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)myelodysplastic syndromes (MDS)chronic myeloid leukemia (CML)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT05304754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05304754.